Daxor Corporation Reports a 37% Increase in NAV to $6.75 Per Share for the Year Ended December 31, 2022

March 2, 2023

https://www.globenewswire.com/news-release/2023/03/02/2619121/0/en/Daxor-Corporation-Reports-a-37-Increase-in-NAV-to-6-75-Per-Share-for-the-Year-Ended-December-31-2022.html

Conference Call to be held today at 9:00 AM EST

Oak Ridge, TN, March 02, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq:DXR), the global leader in blood volume measurement technology, filed its Annual Report to Shareholders on Form N-CSR on March 1, 2023, disclosing its schedule of portfolio holdings as of December 31, 2022.

Read more at globenewswire.com

Related news for (DXR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.